Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 2:58PM AEST - The Australian Stockmarket closes in 1 hour and 7 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
CSL Limited (CSL.AX)
2:38PM AEST:
31.550 AUD
0.000 (0.00%)
MORE ON CSL.AX
Quotes
Summary
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Announcements
Company Events
Message Board
Company
Profile
Key Statistics
Ownership
Insider Trans.
Institutional Trans.
Financials
Earnings Summary
Balance Sheet
Cash Flow
CSL FPO
(ASX:CSL.AX) Delayed quote data
Last Trade:
31.550 AUD
Trade Time:
2:38PM AEST
Change:
0.000 (0.00%)
Prev Close:
31.550
Open:
31.790
Bid:
31.520
Ask:
31.550
1y Target Est:
N/A
Day's Range:
31.450 - 31.850
52wk Range:
28.430 - 38.520
Volume:
1,169,397
Avg Vol
(3m)
:
1,863,390
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add CSL.AX to Portfolio
Download Data
HEADLINES
Swine flu still out there, officials caution
at Reuters
(Sat, Feb 6)
UPDATE - Up to 80 million Americans infected with H1N1 - CDC
at Reuters
(Sat, Jan 16)
Australian shares retreat on profit-taking
Reuters Finance Australia
(Tue, Jan 12)
Australian shares lose 0.9 pct; Foster's gains
Reuters Finance Australia
(Tue, Jan 12)
Aussie dollar off highs, data add to profit-taking
Reuters Finance Australia
(Tue, Jan 12)
Australian shares off 0.6 pct, Alumina slides
Reuters Finance Australia
(Tue, Jan 12)
Countries re-think swine flu vaccine orders
at Reuters
(Tue, Jan 12)
Australian shares slip 0.4 pct, miners down
Reuters Finance Australia
(Tue, Jan 12)
Sanofi says no change in its H1N1 U.S. contracts
at Reuters
(Tue, Jan 12)
U.S. scales back H1N1 vaccine, cuts CSL order in half
at Reuters
(Mon, Jan 11)
More Headlines for CSL.AX...
BUSINESS SUMMARY
CSL Limited (CSL)'s activities comprise the development, manufacture, marketing and distribution of pharmaceutical and allied products. The bulk of its sales are derived from pharmaceutical and bioplasma divisions.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices